B. Riley Securities Initiates Coverage On Precigen with Buy Rating, Announces Price Target of $12

B. Riley Securities has initiated coverage on Precigen (NASDAQ: PGEN) with a Buy rating and set a price target of $12. This marks a positive outlook for the company as it enters the market under new analyst coverage.